Throughout these unusual times, it is necessary to question what actions or initiatives could alleviate possible drug shortages and their impact on cancer patient treatment.

As a response, governments may be more likely to stockpile or limit the exportation of critical cancer drugs when there are shortages. With this in mind, while there are still no severe cancer drug shortages, governments could also investigate long-term resolutions.